TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 34323055

Group type: EXPERIMENTAL
Intervention: ASP medium used during embryo transfer (ET)
Number of subjects: 312

Group type: COMPARATOR
Intervention: No ASP medium used during embryo transfer (ET)
Number of subjects: 312
Study: 33337659

Group type: EXPERIMENTAL
Intervention: Tenapanor 50 mg b.i.d.
Number of subjects: 620

Group type: COMPARATOR
Intervention: Placebo b.i.d.
Number of subjects: 620
Study: 35543938

Group type: EXPERIMENTAL
Intervention: Panlong needling at Jiaji (EX‐B 2) combined with western medication
Number of subjects: 98

Group type: COMPARATOR
Intervention: Western medication alone (levodopa and benserazide hydrochloride tablets)
Number of subjects: 98
Study: 32975296

Group type: EXPERIMENTAL
Intervention: Standard dressing, elastic compression, and REAC TO-RPR treatment
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Standard dressing and REAC TO-RPR treatment
Number of subjects: 30

Group type: COMPARATOR
Intervention: Standard dressing and elastic compression
Number of subjects: 30
Study: 35786344

Group type: EXPERIMENTAL
Intervention: Nano-curcumin (80 mg/day)
Number of subjects: 44

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 44
Study: 32371165

Group type: EXPERIMENTAL
Intervention: Anti-TNF therapy
Number of subjects: 2257
Study: 33109658

Group type: EXPERIMENTAL
Intervention: Usual care plus up to £400 financial incentives
Number of subjects: 0

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 0
Study: 35414414

Group type: EXPERIMENTAL
Intervention: Hypochlorous Acid (HCOL)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Povidone Iodine (PI)
Number of subjects: 60
Study: 32051454

Group type: EXPERIMENTAL
Intervention: Follow-up diagnostic colonoscopy
Number of subjects: 2018

Group type: EXPERIMENTAL
Intervention: Demographic characteristics (younger, Hispanic, Spanish-speaking, zero or one Charlson comorbidity)
Number of subjects: 2018

Group type: EXPERIMENTAL
Intervention: Neighborhood-level predictors
Number of subjects: 2018
Study: 35749710

Group type: EXPERIMENTAL
Intervention: Cannabidiol (CBD) at doses of 75-300 mg
Number of subjects: 18

Group type: COMPARATOR
Intervention: Placebo capsules
Number of subjects: 18
Study: 33691576

Group type: EXPERIMENTAL
Intervention: CRMR treatment (n = 19)
Number of subjects: 38

Group type: COMPARATOR
Intervention: Placebo (n = 19)
Number of subjects: 38
Study: 34695451

Group type: EXPERIMENTAL
Intervention: M1-tDCS
Number of subjects: 26

Group type: EXPERIMENTAL
Intervention: DLPFC-tDCS
Number of subjects: 26

Group type: COMPARATOR
Intervention: Sham-tDCS
Number of subjects: 26
Study: 33606045

Group type: EXPERIMENTAL
Intervention: Alendronate (ALN) 70 mg/week
Number of subjects: 175

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 175
Study: 32678054

Group type: EXPERIMENTAL
Intervention: Dexmedetomidine (DEX)
Number of subjects: 83

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 83
Study: 36200736

Group type: EXPERIMENTAL
Intervention: Non-tracheostomy intervention group
Number of subjects: 128

Group type: COMPARATOR
Intervention: Non-tracheostomy control group
Number of subjects: 128

Group type: EXPERIMENTAL
Intervention: Tracheostomy intervention group
Number of subjects: 128

Group type: COMPARATOR
Intervention: Tracheostomy control group
Number of subjects: 128
Study: 35643729

Group type: EXPERIMENTAL
Intervention: Post-HIFU MRI Likert scale
Number of subjects: 110

Group type: EXPERIMENTAL
Intervention: High suspicion on post-HIFU MRI
Number of subjects: 110

Group type: EXPERIMENTAL
Intervention: More cancer-positive cores on initial biopsy
Number of subjects: 110
Study: 35810836

Group type: EXPERIMENTAL
Intervention: High-intensity physical exercise (20-minute indoor cycling session at 80-90% HRmax)
Number of subjects: 19

Group type: COMPARATOR
Intervention: Control group (no physical exercise)
Number of subjects: 19
Study: 33127585

Group type: EXPERIMENTAL
Intervention: Possession of an analgesic cream
Number of subjects: 127

Group type: COMPARATOR
Intervention: Possession of an anti-itch cream (pain-irrelevant control object)
Number of subjects: 127

Group type: EXPERIMENTAL
Intervention: Prior pain experience (PP condition)
Number of subjects: 127
Study: 32053027

Group type: EXPERIMENTAL
Intervention: EC board games (experimental group)
Number of subjects: 177

Group type: COMPARATOR
Intervention: Off-the-shelf board games (control group)
Number of subjects: 177
Study: 33210287

Group type: EXPERIMENTAL
Intervention: Testosterone
Number of subjects: 429

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 429

Group type: COMPARATOR
Intervention: Testosterone and Placebo
Number of subjects: 429
Study: 32004243

Group type: EXPERIMENTAL
Intervention: Group A: clinical evaluation and ECG every 3 months, echocardiography every 6 months
Number of subjects: 436

Group type: COMPARATOR
Intervention: Group B: clinical evaluation and ECG every 3 months only
Number of subjects: 436
Study: 35844123

Group type: EXPERIMENTAL
Intervention: NOSES group (using the Cai tube)
Number of subjects: 60

Group type: COMPARATOR
Intervention: CL group (conventional laparoscopic surgery)
Number of subjects: 60
Study: 34607820

Group type: EXPERIMENTAL
Intervention: Niraparib plus dostarlimab
Number of subjects: 427

Group type: COMPARATOR
Intervention: Physician's choice chemotherapy
Number of subjects: 427
Study: 32510984

Group type: EXPERIMENTAL
Intervention: Genotype-guided dosing group
Number of subjects: 660

Group type: EXPERIMENTAL
Intervention: Warfarin normal sensitivity group (subgroup of genotype-guided dosing)
Number of subjects: 660

Group type: COMPARATOR
Intervention: Control group (standard dosing)
Number of subjects: 660
Study: 33386336

Group type: EXPERIMENTAL
Intervention: Sensor-based inhaler monitoring
Number of subjects: 252

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 252
Study: 32241376

Group type: EXPERIMENTAL
Intervention: Not available
Number of subjects: 0
Study: 36314486

Group type: EXPERIMENTAL
Intervention: New Forest Parenting Programme (NFPP)
Number of subjects: 93

Group type: COMPARATOR
Intervention: Treatment as usual (TAU)
Number of subjects: 93
Study: 33095999

Group type: EXPERIMENTAL
Intervention: Aerobic exercise (AE)
Number of subjects: 26

Group type: EXPERIMENTAL
Intervention: tDCS (1 mA anodal stimulation to the lower limb motor cortex)
Number of subjects: 26

Group type: EXPERIMENTAL
Intervention: AE+tDCS
Number of subjects: 26

Group type: COMPARATOR
Intervention: Control (AE or tDCS administered alone)
Number of subjects: 26
Study: 32815806

Group type: EXPERIMENTAL
Intervention: Supervised physiotherapy
Number of subjects: 80

Group type: COMPARATOR
Intervention: Home exercises only
Number of subjects: 80
Study: 35831626

Group type: EXPERIMENTAL
Intervention: PHS (spray) + tooth brushing
Number of subjects: 64

Group type: COMPARATOR
Intervention: Tooth brushing
Number of subjects: 64

Group type: EXPERIMENTAL
Intervention: PHS (immersion) + tooth brushing
Number of subjects: 64

Group type: EXPERIMENTAL
Intervention: PHS (spray)
Number of subjects: 64

Group type: EXPERIMENTAL
Intervention: PHS (immersion)
Number of subjects: 64
Study: 34172602

Group type: EXPERIMENTAL
Intervention: 18F‐FDG PET imaging biomarkers
Number of subjects: 31

Group type: EXPERIMENTAL
Intervention: LASSO logistic regression models
Number of subjects: 31

Group type: EXPERIMENTAL
Intervention: Response classification models
Number of subjects: 31

Group type: EXPERIMENTAL
Intervention: Interobserver variability of PET contours
Number of subjects: 31

Group type: EXPERIMENTAL
Intervention: Intraobserver variability between reconstructions
Number of subjects: 31

Group type: EXPERIMENTAL
Intervention: Objective midtreatment PET response assessment
Number of subjects: 31
Study: 35194646

Group type: EXPERIMENTAL
Intervention: Manual physical therapy including desensitization maneuvers of the central nervous system
Number of subjects: 104

Group type: COMPARATOR
Intervention: Surgery
Number of subjects: 104

Group type: EXPERIMENTAL
Intervention: Manual physical therapy
Number of subjects: 104
Study: 34211263

Group type: EXPERIMENTAL
Intervention: Oxymetazoline 0.1%
Number of subjects: 304
Study: 35835925

Group type: EXPERIMENTAL
Intervention: Nebulized hyaluronic acid (HA)
Number of subjects: 48

Group type: COMPARATOR
Intervention: Control (no nebulized HA)
Number of subjects: 48
Study: 32822053

Group type: EXPERIMENTAL
Intervention: Software Package 1
Number of subjects: 81

Group type: COMPARATOR
Intervention: Software Package 2
Number of subjects: 81
Study: 34003156

Group type: EXPERIMENTAL
Intervention: Peripheral neurectomy surgery
Number of subjects: 26

Group type: COMPARATOR
Intervention: Standard medical treatment
Number of subjects: 26
Study: 35403841

Group type: EXPERIMENTAL
Intervention: Nivolumab plus platinum-based chemotherapy
Number of subjects: 0

Group type: COMPARATOR
Intervention: Platinum-based chemotherapy alone
Number of subjects: 0
Study: 33619968

Group type: EXPERIMENTAL
Intervention: Cerebral Embolic Protection Devices (EPDs)
Number of subjects: 123186
Study: 32184135

Group type: EXPERIMENTAL
Intervention: Exercise therapy
Number of subjects: 140

Group type: COMPARATOR
Intervention: Arthroscopic partial meniscectomy
Number of subjects: 140
Study: 34857494

Group type: EXPERIMENTAL
Intervention: IV antimicrobial treatment at home only
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: IV antimicrobial treatment both at home and in hospital
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: IV antimicrobial treatment in hospital only
Number of subjects: 0
Study: 33337592

Group type: EXPERIMENTAL
Intervention: Aerobic training
Number of subjects: 119

Group type: COMPARATOR
Intervention: Wait-list control
Number of subjects: 119
Study: 35164976

Group type: EXPERIMENTAL
Intervention: Transoral laser surgery (TLS)
Number of subjects: 56

Group type: COMPARATOR
Intervention: Radiation therapy (RT)
Number of subjects: 56
Study: 34018861

Group type: EXPERIMENTAL
Intervention: Atezolizumab plus nab-paclitaxel
Number of subjects: 902

Group type: COMPARATOR
Intervention: Placebo plus nab-paclitaxel
Number of subjects: 902
Study: 32561663

Group type: EXPERIMENTAL
Intervention: Apalutamide (240 mg once daily)
Number of subjects: 1207

Group type: EXPERIMENTAL
Intervention: Apalutamide (average daily dose reduced to 209 mg)
Number of subjects: 1207

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1207
Study: 34859616

Group type: EXPERIMENTAL
Intervention: Health professional training and application of a digital screening tool
Number of subjects: 65
Study: 32189088

Group type: EXPERIMENTAL
Intervention: Active Surveillance
Number of subjects: 130

Group type: COMPARATOR
Intervention: Radical Prostatectomy
Number of subjects: 130
Study: 33059293

Group type: EXPERIMENTAL
Intervention: AMZ001 once daily (QD)
Number of subjects: 444

Group type: EXPERIMENTAL
Intervention: AMZ001 twice daily (BID)
Number of subjects: 444

Group type: EXPERIMENTAL
Intervention: AMZ001 BID
Number of subjects: 444

Group type: EXPERIMENTAL
Intervention: AMZ001 QD
Number of subjects: 444

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 444
Study: 36380045

Group type: EXPERIMENTAL
Intervention: Somapacitan
Number of subjects: 120

Group type: COMPARATOR
Intervention: Daily GH
Number of subjects: 120
Study: 32007324

Group type: EXPERIMENTAL
Intervention: 6MWT30 (30-meter track)
Number of subjects: 30

Group type: COMPARATOR
Intervention: 6MWT20 (20-meter track)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: 6MWT30 (for patients walking ≥430 m)
Number of subjects: 30
Study: 32124144

Group type: EXPERIMENTAL
Intervention: Integrated oral language and listening comprehension intervention, delivered in small groups of 3 or 4, 4 days per week for 20 weeks
Number of subjects: 43

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 43
Study: 32658089

Group type: EXPERIMENTAL
Intervention: Educational gaming activity
Number of subjects: 844

Group type: COMPARATOR
Intervention: Control group (no educational gaming)
Number of subjects: 844
Study: 32620543

Group type: EXPERIMENTAL
Intervention: 20 mL/kg up to 1000 mL of normal saline (fluid bolus group)
Number of subjects: 58

Group type: COMPARATOR
Intervention: 5 mL of normal saline (control group)
Number of subjects: 58

Group type: EXPERIMENTAL
Intervention: Fluid bolus group
Number of subjects: 58

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 58
Study: 36372660

Group type: EXPERIMENTAL
Intervention: eHealth behavior change support (BCS) program delivered on Facebook and texts for 10 weeks
Number of subjects: 0

Group type: COMPARATOR
Intervention: Not applicable
Number of subjects: 0
Study: 33993331

Group type: EXPERIMENTAL
Intervention: 2‐mSv CT (n = 1535)
Number of subjects: 3074

Group type: COMPARATOR
Intervention: Conventional-dose CT (CDCT, n = 1539)
Number of subjects: 3074

Group type: EXPERIMENTAL
Intervention: 2‐mSv CT
Number of subjects: 3074

Group type: COMPARATOR
Intervention: Conventional-dose CT (CDCT)
Number of subjects: 3074
Study: 34448856

Group type: EXPERIMENTAL
Intervention: Multidomain lifestyle intervention (healthy diet, physical, social and cognitive activity, management of cardiovascular risks)
Number of subjects: 27

Group type: EXPERIMENTAL
Intervention: Healthcare professionals' perceptions of the lifestyle intervention
Number of subjects: 27

Group type: EXPERIMENTAL
Intervention: Education on dementia prevention
Number of subjects: 27

Group type: EXPERIMENTAL
Intervention: Coordination of work and adequate resources
Number of subjects: 27

Group type: EXPERIMENTAL
Intervention: Multiprofessional collaboration
Number of subjects: 27
Study: 32853117

Group type: EXPERIMENTAL
Intervention: Pattern discrimination task at 3500 Hz CF
Number of subjects: 2

Group type: EXPERIMENTAL
Intervention: Pattern discrimination task at 750 Hz CF
Number of subjects: 2

Group type: EXPERIMENTAL
Intervention: Selective attention to frequency with instruction
Number of subjects: 2

Group type: EXPERIMENTAL
Intervention: Divided attention, assessing inherent frequency biases
Number of subjects: 2

Group type: COMPARATOR
Intervention: Pattern discrimination task in quiet
Number of subjects: 2
Study: 36121865

Group type: EXPERIMENTAL
Intervention: CSB-MNP-A (multiple micronutrients containing zinc)
Number of subjects: 346

Group type: COMPARATOR
Intervention: Control (standard CSB fortified with multiple micronutrients)
Number of subjects: 346

Group type: EXPERIMENTAL
Intervention: CSB-MNP-B (multiple micronutrients without zinc)
Number of subjects: 346

Group type: EXPERIMENTAL
Intervention: CSB-MNP-C (zinc only)
Number of subjects: 346
Study: 32150432

Group type: EXPERIMENTAL
Intervention: Behavioral Inhibition System (BIS)
Number of subjects: 328

Group type: EXPERIMENTAL
Intervention: Behavioral Activation System (BAS)
Number of subjects: 328
Study: 32777789

Group type: EXPERIMENTAL
Intervention: Vismodegib
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Sonidegib
Number of subjects: 0
Study: 37074807

Group type: EXPERIMENTAL
Intervention: 50 g mannitol
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: 100 g mannitol
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: 150 g mannitol
Number of subjects: 0
Study: 33904329

Group type: EXPERIMENTAL
Intervention: Inoculation with L. pseudotheobromae
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: Inoculation with L. theobromae
Number of subjects: 9

Group type: COMPARATOR
Intervention: Control group (sterile PDA plugs)
Number of subjects: 9
Study: 36369247

Group type: EXPERIMENTAL
Intervention: Baduanjin exercise (BDJ)
Number of subjects: 98

Group type: EXPERIMENTAL
Intervention: Aerobic training (AT)
Number of subjects: 98

Group type: COMPARATOR
Intervention: Control group (no exercise)
Number of subjects: 98
Study: 33002684

Group type: EXPERIMENTAL
Intervention: PoMeT (Positive Memory Training)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Treatment as usual
Number of subjects: 100
Study: 36288470

Group type: EXPERIMENTAL
Intervention: mHealth intervention
Number of subjects: 74

Group type: EXPERIMENTAL
Intervention: mHealth plus intervention (includes nurse practitioner and community health worker)
Number of subjects: 74

Group type: COMPARATOR
Intervention: Enhanced usual care (control group)
Number of subjects: 74
Study: 34768093

Group type: EXPERIMENTAL
Intervention: Pitch-shift stimuli during vocalization of a steady speech vowel sound /a/
Number of subjects: 34

Group type: EXPERIMENTAL
Intervention: Pitch-shift stimuli during listening to playback of self‐produced vowel vocalizations
Number of subjects: 34

Group type: COMPARATOR
Intervention: No pitch-shift stimuli during vocalization and listening tasks (control condition)
Number of subjects: 34
Study: 34648235

Group type: EXPERIMENTAL
Intervention: Guided intervention (n=142) with adherence-focused guidance
Number of subjects: 576

Group type: EXPERIMENTAL
Intervention: Unguided intervention (n=146) without guidance
Number of subjects: 576

Group type: COMPARATOR
Intervention: Waiting-list control (n=144)
Number of subjects: 576
Study: 32039957

Group type: EXPERIMENTAL
Intervention: TO (anchorless technique)
Number of subjects: 166

Group type: COMPARATOR
Intervention: TOE (anchored technique)
Number of subjects: 166
Study: 35164831

Group type: EXPERIMENTAL
Intervention: Erector spinae plane block (ESPB)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Thoracic paravertebral block (TPVB)
Number of subjects: 40
Study: 32059687

Group type: EXPERIMENTAL
Intervention: HI-FIVES intervention
Number of subjects: 241

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 241
Study: 33998349

Group type: EXPERIMENTAL
Intervention: Peripheral cannulation
Number of subjects: 44

Group type: COMPARATOR
Intervention: Central cannulation
Number of subjects: 44
Study: 34656656

Group type: EXPERIMENTAL
Intervention: AI-based diagnostic-support software (dentalXrai Pro)
Number of subjects: 22

Group type: COMPARATOR
Intervention: No AI support
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: AI-based diagnostic-support software
Number of subjects: 22
Study: 35522660

Group type: EXPERIMENTAL
Intervention: Voice activated technology
Number of subjects: 0

Group type: COMPARATOR
Intervention: Standard of care (SOC)
Number of subjects: 0
Study: 32823839

Group type: EXPERIMENTAL
Intervention: Animal-Assisted Therapy (AAT) with a therapy dog
Number of subjects: 46

Group type: COMPARATOR
Intervention: Physiotherapy (Control Group)
Number of subjects: 46
Study: 33200892

Group type: EXPERIMENTAL
Intervention: Sotagliflozin
Number of subjects: 1222

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1222
Study: 36098051

Group type: EXPERIMENTAL
Intervention: Empagliflozin
Number of subjects: 5988

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 5988
Study: 34760706

Group type: EXPERIMENTAL
Intervention: Single-Incision Laparoscopic Surgery (SILS)
Number of subjects: 200

Group type: COMPARATOR
Intervention: Conventional Laparoscopic Surgery (CLS)
Number of subjects: 200
Study: 36169717

Group type: EXPERIMENTAL
Intervention: One-point flow cytometric MRD measurement at end of induction (EOI) with a threshold of 0.01%
Number of subjects: 227

Group type: EXPERIMENTAL
Intervention: Combination of clinical parameters and one-point MRD measurement
Number of subjects: 227
Study: 36412168

Group type: EXPERIMENTAL
Intervention: Day-zero ambulation (walking on the same day as the operation)
Number of subjects: 36

Group type: COMPARATOR
Intervention: Standard post-operative physiotherapy (control group)
Number of subjects: 36
Study: 34088338

Group type: EXPERIMENTAL
Intervention: Credelio Plus® (lotilaner and milbemycin oxime) administered orally at a dose rate of 20.0-41.5 mg/kg bodyweight once every 4 weeks for 3 months
Number of subjects: 419

Group type: COMPARATOR
Intervention: Nexgard Spectra® (control product) administered as recommended once every 4 weeks for 3 months
Number of subjects: 419

Group type: EXPERIMENTAL
Intervention: Both treatment groups (Credelio Plus® and Nexgard Spectra®)
Number of subjects: 419
Study: 35689282

Group type: EXPERIMENTAL
Intervention: InterTan nail
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Femoral neck system (FNS)
Number of subjects: 18

Group type: COMPARATOR
Intervention: Three cannulated screws
Number of subjects: 18
Study: 35075359

Group type: EXPERIMENTAL
Intervention: Proprioceptive training group (PG); n=20
Number of subjects: 40

Group type: COMPARATOR
Intervention: Nonspecific sensory stimulation (control group [CG]); n=20
Number of subjects: 40
Study: 34743149

Group type: EXPERIMENTAL
Intervention: Nomogram based on clinicopathologic variables (including ER+, PR+, HER2+ with Herceptin treatment, low ALNR) for predicting overall survival (OS)
Number of subjects: 345

Group type: EXPERIMENTAL
Intervention: Nomogram for predicting OS
Number of subjects: 345
Study: 32517663

Group type: EXPERIMENTAL
Intervention: Nonavalent HPV vaccination (3 injections)
Number of subjects: 750

Group type: COMPARATOR
Intervention: Placebo injections (NaCL 0.9%)
Number of subjects: 750
Study: 34988724

Group type: EXPERIMENTAL
Intervention: Indoor exercise
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Outdoor exercise
Number of subjects: 120

Group type: COMPARATOR
Intervention: Untrained
Number of subjects: 120
Study: 34153136

Group type: EXPERIMENTAL
Intervention: Telephone-based Cognitive Behaviour Therapy (T-CBT)
Number of subjects: 78

Group type: COMPARATOR
Intervention: Treatment as Usual Cognitive Behaviour Therapy (TAU-CBT)
Number of subjects: 78
Study: 32668111

Group type: EXPERIMENTAL
Intervention: Ticagrelor (180 mg loading dose followed by 90 mg twice daily) plus Aspirin (300 to 325 mg on the first day followed by 75 to 100 mg daily)
Number of subjects: 11016

Group type: COMPARATOR
Intervention: Aspirin (300 to 325 mg on the first day followed by 75 to 100 mg daily)
Number of subjects: 11016

Group type: EXPERIMENTAL
Intervention: Ticagrelor-aspirin
Number of subjects: 11016

Group type: COMPARATOR
Intervention: Aspirin
Number of subjects: 11016
Study: 35473729

Group type: EXPERIMENTAL
Intervention: 7.5 mg prednisolone for 1 week
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: 30 mg prednisolone for 1 week
Number of subjects: 24

Group type: COMPARATOR
Intervention: 1.125 mg dexamethasone per day for 1 week
Number of subjects: 24

Group type: COMPARATOR
Intervention: 4.5 mg dexamethasone per day for 1 week
Number of subjects: 24
Study: 33856860

Group type: EXPERIMENTAL
Intervention: Aerobic exercise intervention (5 d/wk, 20 min/d, 100 min/wk)
Number of subjects: 37

Group type: COMPARATOR
Intervention: Standard of care
Number of subjects: 37

Group type: EXPERIMENTAL
Intervention: Exercise volume <100 min/wk
Number of subjects: 37

Group type: EXPERIMENTAL
Intervention: Exercise volume ≥160 min/wk
Number of subjects: 37

Group type: EXPERIMENTAL
Intervention: Greater exercise volume
Number of subjects: 37
Study: 33436279

Group type: EXPERIMENTAL
Intervention: Web-based educational video about lung cancer screening (LCS)
Number of subjects: 1281

Group type: COMPARATOR
Intervention: Usual care (control group)
Number of subjects: 1281
Study: 32541874

Group type: EXPERIMENTAL
Intervention: Pavlik harness
Number of subjects: 104

Group type: COMPARATOR
Intervention: Active surveillance
Number of subjects: 104

Group type: COMPARATOR
Intervention: Standard of care (acetabular index at age 10 months)
Number of subjects: 104

Group type: COMPARATOR
Intervention: Standard of care (walking age)
Number of subjects: 104